Healthcare provider profile · identity verified

Indumathi Christopher, MD

Allopathic & Osteopathic Physicians|Family Medicine|Geriatric Medicine · CRESTVIEW, FL · NPI 1467453613

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Indumathi Christopher, MD received $40.74 in general payments during 2025 across 2 reported records.

Otsuka America Pharmaceutical, Inc. accounted for 54.0% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 2 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Rexulti.

Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 76 claims for Ozempic by this doctor in 2024.

Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 160756 records involving 46288 distinct recipient NPIs. Public Medicare Part D data also shows 96 claims for Rexulti by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$40.74

2 reported records · 2 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Otsuka America Pharmaceutical, Inc.	Unresolved — no canonical attribution shown	$22.01	54.0%	1	2025
Novo Nordisk Inc	Unresolved — no canonical attribution shown	$18.73	46.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$40.74	2

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
REXULTI Normalized: rexulti	Drug	Otsuka America Pharmaceutical, Inc.	$22.01	1	2025
Source payment records 2025-12-17 · Otsuka America Pharmaceutical, Inc. · $22.01 · Open Payments source
Wegovy Normalized: wegovy	Drug	Novo Nordisk Inc	$18.73	1	2025
Source payment records 2025-04-05 · Novo Nordisk Inc · $18.73 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
REXULTI rexulti	2025	Rexulti	2024	96	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Novo Nordisk Inc Exact reporting entity; no affiliate inference	2025	Ozempic open payments reported associated product	CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076	Ozempic · 2024 Exact normalized brand match · 1 Part D row	76	22
Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference	2025	REXULTI open payments reported associated product	CMS Open Payments — General Payments 160756 supporting records · 46288 recipient NPIs · example record 1227267708	Rexulti · 2024 Exact normalized brand match · 1 Part D row	96	11

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	740	169
Atorvastatin Calcium	Atorvastatin Calcium	729	183
Losartan Potassium	Losartan Potassium	648	160
Eliquis	Apixaban	480	63
Amlodipine Besylate	Amlodipine Besylate	462	116
Gabapentin	Gabapentin	456	117
Furosemide	Furosemide	453	108
Rosuvastatin Calcium	Rosuvastatin Calcium	422	122
Escitalopram Oxalate	Escitalopram Oxalate	404	86
Jardiance	Empagliflozin	360	66
Omeprazole	Omeprazole	351	105
Mounjaro	Tirzepatide	337	54
Lisinopril	Lisinopril	319	86
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	318	53
Potassium Chloride	Potassium Chloride	294	62
Metoprolol Tartrate	Metoprolol Tartrate	287	65
Pantoprazole Sodium	Pantoprazole Sodium	286	81
Tramadol Hcl	Tramadol Hcl	282	83
Metoprolol Succinate	Metoprolol Succinate	270	71
Carvedilol	Carvedilol	264	58
Alprazolam	Alprazolam	263	68
Sertraline Hcl	Sertraline Hcl	261	63
Memantine Hcl	Memantine Hcl	254	47
Donepezil Hcl	Donepezil Hcl	247	51
Duloxetine Hcl	Duloxetine Hcl	243	50
Myrbetriq	Mirabegron	243	19
Metformin Hcl Er	Metformin Hcl	225	65
Simvastatin	Simvastatin	221	59
Tamsulosin Hcl	Tamsulosin Hcl	207	55
Famotidine	Famotidine	192	56
Prednisone	Prednisone	187	122
Trazodone Hcl	Trazodone Hcl	179	51
Clopidogrel	Clopidogrel Bisulfate	170	42
Spironolactone	Spironolactone	164	31
Clonazepam	Clonazepam	160	23
Metformin Hcl	Metformin Hcl	159	45
Pregabalin	Pregabalin	156	32
Glipizide Er	Glipizide	148	36
Hydralazine Hcl	Hydralazine Hcl	133	35
Allopurinol	Allopurinol	124	33
Hydrochlorothiazide	Hydrochlorothiazide	118	42
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	117	13
Montelukast Sodium	Montelukast Sodium	114	38
Aripiprazole	Aripiprazole	111	16
Azithromycin	Azithromycin	109	88
Lorazepam	Lorazepam	106	23
Entresto	Sacubitril/Valsartan	105	15
Doxycycline Hyclate	Doxycycline Hyclate	104	63
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	102	33
Temazepam	Temazepam	101	11
Venlafaxine Hcl Er	Venlafaxine Hcl	101	19
Meloxicam	Meloxicam	98	30
Quetiapine Fumarate	Quetiapine Fumarate	97	26
Rexulti	Brexpiprazole	96	11
Pravastatin Sodium	Pravastatin Sodium	94	21
Albuterol Sulfate Hfa	Albuterol Sulfate	93	39
Divalproex Sodium	Divalproex Sodium	92	12
Fluticasone Propionate	Fluticasone Propionate	84	34
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	82	21
Nebivolol Hcl	Nebivolol Hcl	82	19
Fluconazole	Fluconazole	79	47
Januvia	Sitagliptin Phosphate	77	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	77	19
Ozempic	Semaglutide	76	22
Synthroid	Levothyroxine Sodium	73	17
Xarelto	Rivaroxaban	73	12
Zolpidem Tartrate	Zolpidem Tartrate	73	13
Ezetimibe	Ezetimibe	72	18
Olanzapine	Olanzapine	72	11
Oxybutynin Chloride Er	Oxybutynin Chloride	71	15
Baclofen	Baclofen	70	15
Buspirone Hcl	Buspirone Hcl	69	16
Olmesartan Medoxomil	Olmesartan Medoxomil	68	19
Estradiol	Estradiol	66	18
Chlorthalidone	Chlorthalidone	63	17
Levetiracetam	Levetiracetam	63	suppressed
Levofloxacin	Levofloxacin	60	49
Cefdinir	Cefdinir	59	44
Finasteride	Finasteride	58	15
Valacyclovir	Valacyclovir Hcl	58	21
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	57	33
Pioglitazone Hcl	Pioglitazone Hcl	57	19
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	56	36
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	54	49
Fentanyl	Fentanyl	54	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	54	18
Bupropion Xl	Bupropion Hcl	52	15
Farxiga	Dapagliflozin Propanediol	52	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	52	14
Clonidine Hcl	Clonidine Hcl	51	19
Tresiba Flextouch U-100	Insulin Degludec	50	17
Fluoxetine Hcl	Fluoxetine Hcl	48	suppressed
Propranolol Hcl	Propranolol Hcl	47	15
Ropinirole Hcl	Ropinirole Hcl	47	11
Anastrozole	Anastrozole	46	suppressed
Ondansetron Hcl	Ondansetron Hcl	45	30
Celecoxib	Celecoxib	44	17
Amitriptyline Hcl	Amitriptyline Hcl	42	12
Soliqua 100-33	Insulin Glargine/Lixisenatide	42	13
Trulicity	Dulaglutide	42	13
Atenolol	Atenolol	41	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	40	11
Nystatin	Nystatin	40	25
Clobetasol Propionate	Clobetasol Propionate	39	27
Ipratropium Bromide	Ipratropium Bromide	38	14
Linzess	Linaclotide	38	11
Topiramate	Topiramate	37	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	34	11
Carbidopa-Levodopa	Carbidopa/Levodopa	34	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	34	16
Tizanidine Hcl	Tizanidine Hcl	34	18
Breo Ellipta	Fluticasone/Vilanterol	33	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	33	suppressed
Sotalol	Sotalol Hcl	33	suppressed
Citalopram Hbr	Citalopram Hydrobromide	31	suppressed
Primidone	Primidone	31	suppressed
Ventolin Hfa	Albuterol Sulfate	31	13
Cefuroxime	Cefuroxime Axetil	30	17
Lamotrigine	Lamotrigine	30	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	30	suppressed
Diltiazem Hcl	Diltiazem Hcl	29	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	29	suppressed
Haloperidol Decanoate	Haloperidol Decanoate	29	suppressed
Lactulose	Lactulose	29	suppressed
Fenofibrate	Fenofibrate	28	suppressed
Latanoprost	Latanoprost	28	suppressed
Lovastatin	Lovastatin	28	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	27	suppressed
Diclofenac Sodium	Diclofenac Sodium	26	suppressed
Mupirocin	Mupirocin	26	17
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	26	suppressed
Solifenacin Succinate	Solifenacin Succinate	26	suppressed
Zonisamide	Zonisamide	26	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Gemtesa	Vibegron	25	suppressed
Insulin Aspart Flexpen	Insulin Aspart	25	suppressed
Novolog Flexpen	Insulin Aspart	25	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	24	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	24	suppressed
Cephalexin	Cephalexin	24	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	24	13
Budesonide	Budesonide	23	suppressed
Doxepin Hcl	Doxepin Hcl	23	suppressed
Mirtazapine	Mirtazapine	23	suppressed
Ingrezza	Valbenazine Tosylate	22	suppressed
Ketoconazole	Ketoconazole	22	14
Tacrolimus	Tacrolimus	22	suppressed
Azelastine Hcl	Azelastine Hcl	20	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	20	suppressed
Levemir Flexpen	Insulin Detemir	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	13
Ursodiol	Ursodiol	20	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	16
Labetalol Hcl	Labetalol Hcl	19	suppressed
Midodrine Hcl	Midodrine Hcl	19	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	19	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	19	18
Phenytoin Sodium Extended	Phenytoin Sodium Extended	19	suppressed
Telmisartan	Telmisartan	19	suppressed
Tresiba Flextouch U-200	Insulin Degludec	19	suppressed
Carbamazepine Er	Carbamazepine	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Dexamethasone	Dexamethasone	17	16
Digoxin	Digoxin	17	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Ultra-Fine Micro Pen Needle	Pen Needle, Diabetic	17	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	17	suppressed
Insulin Lispro	Insulin Lispro	16	suppressed
Methimazole	Methimazole	16	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Amoxicillin	Amoxicillin	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Lubiprostone	Lubiprostone	15	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	15	suppressed
Tobramycin	Tobramycin	15	11
Acyclovir	Acyclovir	14	suppressed
Albuterol Sulfate	Albuterol Sulfate	14	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Brilinta	Ticagrelor	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	14	suppressed
Lithium Carbonate	Lithium Carbonate	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Valsartan	Valsartan	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	13	suppressed
Diazepam	Diazepam	13	13
Dovato	Dolutegravir Sodium/Lamivudine	13	suppressed
Febuxostat	Febuxostat	13	suppressed
Humalog Kwikpen U-200	Insulin Lispro	13	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	13	suppressed
Calcitriol	Calcitriol	12	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Diltiazem 12hr Er	Diltiazem Hcl	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Letrozole	Letrozole	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	12	suppressed
Santyl	Collagenase Clostridium Hist.	12	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	11	suppressed
Folic Acid	Folic Acid	11	suppressed
Ibandronate Sodium	Ibandronate Sodium	11	suppressed
Nystop	Nystatin	11	suppressed
Vascepa	Icosapent Ethyl	11	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$40.74 · 2 records	Otsuka America Pharmaceutical, Inc.	REXULTI, Wegovy	2	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Rexulti play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error